data safety monitoring board

(redirected from Data and Safety Monitoring Board)

data safety monitoring board

, data and safety monitoring board,

DSMB

An independent group of scientists and concerned community members who oversee the interim findings of a research project to determine whether the research undertaken is proceeding without evidence of harm to the subjects enrolled in the study.
Mentioned in ?
References in periodicals archive ?
Monitoring exists on a continuum from monitoring by the principal investigator/project manager or NIH program staff to a data and safety monitoring board.
The action was taken on July 19, 2004 and followed the unanimous recommendations of both the trial's independent Data and Safety Monitoring Board (DSMB) and its Steering Committee.
The action was taken on July 19th and followed the unanimous recommendations of both the trial's independent Data and Safety Monitoring Board (DSMB) and its Steering Committee.
The study was closed early by an independent Data and Safety Monitoring Board (DSMB) that reviewed an earlier analysis and determined that enrolling additional patients could not be justified.
In early October, the company suspended new patient accrual pending the independent Data and Safety Monitoring Board (DSMB) and FDA review of an interim safety analysis.
The study was terminated early by the study's independent Data and Safety Monitoring Board (DSMB) due to significantly improved total survival for those heart attack survivors receiving an implantable defibrillator compared to those receiving conventional treatment.
Nasdaq:CLPA) today announced that the independent Data and Safety Monitoring Board (DSMB) recommended resuming enrollment in the Company's phase III lung cancer trial of Aptosyn(TM) (exisulind) and Taxotere(R).
Recruitment to this randomized, double-blind, placebo-controlled trial was stopped based on the recommendation of the National Cancer Institute/Center for Cancer Research's Data and Safety Monitoring Board (DSMB), which determined that the trial had reached its pre-specified efficacy endpoint at the second interim analysis.
Cerus Corporation (Nasdaq:CERS) today announced that it has received final clearance from an independent Data and Safety Monitoring Board (DSMB) to complete enrollment in its ongoing U.
NASDAQ:IPIC) today announced that it has been notified that the BEST (Beta-blocker Evaluation of Survival Trial) trial of BEXTRA(R) (bucindolol) has been terminated at the recommendation of the BEST Data and Safety Monitoring Board, based upon the absence of significant survival advantage of treatment with bucindolol.
CYTR announced yesterday that its independent Data and Safety Monitoring Board (DSMB) had examined the efficacy and safety results from the first 112 patients enrolled in the Pivotal Phase III clinical trial of FLOCOR for the treatment of acute sickle cell crisis.
Recently, a Data and Safety Monitoring Board was convened for the independent analysis of interim data is limited by the U.

Full browser ?